Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bill Gates Says Boko Haram Slowing Anti-Polio Efforts in Nigeria

July 24 (Bloomberg) -- The insurgency by Boko Haram militants in northern Nigeria is affecting a donor-backed target to record no cases of polio in the West African nation by next year, said billionaire philanthropist Bill Gates.

Authorities suspect gunmen from the Islamist group abducted three health workers giving vaccinations in Bauchi state in March and killed nine others in attacks on polio immunization centers in the northern city of Kano last year.

“This Boko Haram disruption is the one real cloud on the horizon where it means there are groups of children we’re not able to get to,” Gates told reporters today in Ethiopia’s capital, Addis Ababa. “So we’re hopeful that won’t get even more intense.”

Boko Haram, which means “western education is a sin” in the local Hausa language, has waged a five-year campaign to impose Islamic law on Africa’s most populous nation. It has focused its insurgency in the northeastern states of Borno, Yobe and Adamawa and carried out attacks in Abuja, the capital.

The Bill and Melinda Gates Foundation supports the Global Polio Eradication Initiative in three polio-endemic nations - Nigeria, Afghanistan and Pakistan - as well as other African countries where there’s a risk the disease could spread.

To contact the reporter on this story: William Davison in Addis Ababa at

To contact the editors responsible for this story: Nasreen Seria at Sarah McGregor, Karl Maier

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.